geranylgeraniol has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, Y; Hara, K; Morita, I; Murota, S; Nakamura, T | 1 |
| Fujita, H; Hiruma, Y; Morita, I; Nakahama, K | 1 |
2 other study(ies) available for geranylgeraniol and dinoprostone
| Article | Year |
|---|---|
The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain.
Topics: Acid Phosphatase; Analysis of Variance; Animals; Bone Resorption; Calcitriol; Calcium; Cells, Cultured; Dinoprostone; Diterpenes; Giant Cells; Male; Mice; Mice, Inbred ICR; Organ Culture Techniques; Osteoclasts; Phytol; Spleen; Stromal Cells; Structure-Activity Relationship; Vitamin K; Vitamin K 1; Vitamin K 2; Warfarin | 1995 |
Vitamin K2 and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner.
Topics: Animals; Cell Division; Cell Line; Coculture Techniques; Cyclooxygenase 2; Dinoprostone; Diphosphonates; Diterpenes; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Isoenzymes; Male; Mice; Mice, Inbred Strains; Osteoclasts; Prostaglandin-Endoperoxide Synthases; Protein Subunits; Spleen; Vitamin K 2 | 2004 |